Recent advances in enterotoxin vaccine adjuvants
Open Access
- 16 November 2023
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 85, 102398
Abstract
No abstract availableKeywords
Funding Information
- NIAID
This publication has 58 references indexed in Scilit:
- Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesVaccine, 2019
- A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against Yersinia Infection in Adult and Infant MiceThe Journal of Immunology, 2019
- Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challengeVaccine, 2019
- Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumoniaVaccine, 2019
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLTmSphere, 2018
- Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in MicePLOS ONE, 2015
- Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I studyVaccine, 2014
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile ToxinPLOS ONE, 2009
- Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal TractInfection and Immunity, 2005
- Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in SwitzerlandNew England Journal of Medicine, 2004